KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Assets (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Return on Assets for 15 consecutive years, with 0.06% as the latest value for Q1 2025.

  • On a quarterly basis, Return on Assets changed N/A to 0.06% in Q1 2025 year-over-year; TTM through Mar 2025 was 0.06%, a N/A change, with the full-year FY2025 number at 0.08%, changed N/A from a year prior.
  • Return on Assets was 0.06% for Q1 2025 at Bristol Myers Squibb, up from 0.1% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.07% in Q3 2022 to a low of 0.1% in Q4 2024.
  • A 4-year average of 0.03% and a median of 0.06% in 2021 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: increased 14bps in 2021, then changed 0bps in 2022.
  • Bristol Myers Squibb's Return on Assets stood at 0.06% in 2021, then rose by 2bps to 0.07% in 2022, then plummeted by -247bps to 0.1% in 2024, then surged by 161bps to 0.06% in 2025.
  • Per Business Quant, the three most recent readings for BMY's Return on Assets are 0.06% (Q1 2025), 0.1% (Q4 2024), and 0.07% (Q4 2022).